Skip to content

Kluwer Patent Blog

Kluwer Patent Blog
  • Facebook
  • X
  • LinkedIn
  • YouTube

Patents

A patent is a document, issued, upon application, by a government office (or a regional office acting for several countries), which describes an invention and creates a legal situation in which the patented invention can normally only be exploited (manufactured, used, sold, imported) with the authorization of the holder of the patent. ‘Invention’ means a solution to a specific problem in the field of technology. An invention may relate to a product or a process. The protection conferred by the patent is limited in time, generally 20 years. In a number of countries, inventions are also protectable through registration of a ‘utility model’ or ‘short-term patent’.

AI, Patents

Wolters Kluwer partners with AI analytics company, Aistemos.

Nigel Swycher (Aistemos)/October 27, 2017May 11, 2023

Kluwer IP Law announced in September that it was partnering with Aistemos, to distribute Cipher Reports, the latest in AI over IP. This is the back story. Patents date back 400 years, so nothing new. What has evolved is the importance and value of patents, and intangible assets more generally. For the vast majority of…

Continue reading
Patents

Top 3 Posts from March and April from our IP Law blogs

Kluwer Patent Blog/May 5, 2017May 4, 2017

To ensure you don’t miss out on interesting IP law developments reported on our other IP blogs, we will, on a regular basis, provide you with an overview of the top 3 most-read posts from each of our IP law blogs.  Here are the top posts from March and April. Top 3 Kluwer Copyright Blog…

Continue reading
Patents

Kluwer Patent Blog Poll

Rik Lambers (Brinkhof)/June 28, 2013March 18, 2017

Now is the winter of our discontent, or so some may have thought when the Unified Patent Court (“UPC”) agreement was signed on 19 February of this year. The rain came mainly from Spain, which started a fresh challenge to the legality of the Unitary Patent and Language Regulations before the CJEU this spring. And…

Continue reading

Posts navigation

«‹293031
Wolters Kluwer

Go to posts on

(Compulsory) license (Cross-border) jurisdiction (Indirect) infringement Amendments Biologics Brexit Case Law Chemical Engineering Damages Denmark Enforcement EPC EPO EPO Decision Equivalents European Union Exceptions to patentability Extent of Protection France FRAND Germany Infringement Injunction Inventive step Italy Litigation Netherlands Novelty Opposition Patents Pharma Pharmaceutical patent Procedure Revocation Scope of protection SEP Spain SPC Sufficiency of disclosure Switzerland Unitary Patent United Kingdom United States of America UPC Validity
VAEPC-2024-edVissers Annotated European Patent Convention 2024 EditionKaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105
Annotated-PCTAnnotated PCTMalte Köllner€ 160
AI-GovernanceAI Governance and Liability in Europe: A Primer Ceyhun Necati Pehlivan, Nikolaus Forgó, Peggy Valcke€ 150

Number 3 in Top 10 Pharma Patent Blogs To Follow in 2022!

Pharma Patent Blogs

Blog Contributors

  • Brian Cordery
    Bristows
  • Rik Lambers
    Brinkhof
  • Rachel Mumby
    Bristows
  • Daniela Ampollini
    Trevisan & Cuonzo
  • Thorsten Bausch
    Hoffmann Eitle
  • Enrico Bonadio
    City, University of London
  • John Collins
    Clayton Utz
  • Matthieu Dhenne
    Dhenne Avocats
  • Simon Holzer
    MLL Legal Ltd.
  • Adam Lacy
    Hoffmann Eitle
  • Vaishali Mittal
    Anand and Anand
  • Miquel Montañá
    Clifford Chance
  • Roberto Rodrigues Pinho
    RNA Law
  • Alexa von Uexküll
    Vossius & Partner
  • Anders Valentin
    Bugge Valentin

Kluwer IP Law News Alert

Stay informed on Intellectual Property law & developments

Search Posts

RSS feeds

Summary Feed Article Feed

Related Sites

  • Kluwer IP Law
  • Kluwer Copyright Blog
  • Kluwer Trademark Blog
  • Regulating for Globalization Blog
  • Author Portal
Kluwer Logo

About us

  • About Kluwer Patent Blog
  • Kluwer IP Law
  • Kluwer Law International
  • E-store
  • Authors

Legal policy

  • User Agreement and Disclaimer
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies

Contact

  • General Information
Back to top